COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,884 Articles (22,568 medRxiv, 8,316 bioRxiv)

Most recent first Previous |  Page 2293: Articles 22921-22930  | Next

Development of antibodies to pan-coronavirus spike peptides in convalescent COVID-19 patients
Rabets, A., Bila, G., Grytsko, R., Samborsky, M., Rebets, Y., Vari, S., Pagneux, Q., Barras, A., Boukherroub, R., Szunerits, S., Bilyy, R.
10.1101/2020.08.20.20178566 — Posted: 2020-08-22
COVID-19 Pandemic Preparedness in a United Kingdom Tertiary and Quaternary Children`s Hospital: Tales of the Unexpected
Alders, N., Penner, J., Grant, K., Patterson, C., Hassell, J., MacDermott, N., Pincott, S., Bamford, A., du Pre, P., Johnson, M., Moshal, K.
10.1101/2020.08.20.20178541 — Posted: 2020-08-22
Clinical Characteristics and Outcomes of Diabetic COVID-19 patients in Kuwait
Ali, H., Alshukry, A., Bu Abbas, M., Ali, Y., Alahmad, B., Al-Shammari, A. A., Abu-farha, M., Abubakr, J., Devarajan, S., Dashti, A. A., Al-Mulla, F.
10.1101/2020.08.20.20178525 — Posted: 2020-08-22
Inhaled corticosteroids downregulate SARS-CoV-2-related gene expression in COPD: results from a RCT
Milne, S., Li, X., Yang, C. X., Hernandez Cordero, A. I., Leitao Filho, F. S., Yang, C. W. T., Shaipanich, T., van Eeden, S. F., Leung, J. M., Lam, S., Sin, D. D.
10.1101/2020.08.19.20178368 — Posted: 2020-08-22
SARS-Cov-2 proliferation: an analytical aggregate-level model
Pitschel, T.
10.1101/2020.08.20.20178301 — Posted: 2020-08-22
Clinical Characteristics and Outcomes of COVID-19 Positive Acute Coronary Syndrome Patients; a multisource Electronic Healthcare Records Study from England
Rashid, M., Wu, J., Timmis, A., Curzen, N., Zaman, A., Clarke, S., Nolan, J., Shoiab, A., Mohamed, M. O., De Belder, M., Deanfield, J., Gale, C., Mamas, M.
10.1101/2020.08.20.20175091 — Posted: 2020-08-22
Serum neopterin levels in relation to mild and severe COVID-19
Robertson, J., Gostner, J. M., Nilsson, S., Andersson, L.-M., Fuchs, D., Gisslen, M.
10.1101/2020.08.19.20178178 — Posted: 2020-08-22
Longitudinal analysis of virus load, serum antibody levels and virus neutralizing activity in vitro in cases with less severe COVID-19
Flehmig, B., Schindler, M., Ruetalo, N., Businger, R., Bayer, M., Haage, A., Kirchner, T., Klingel, K., Normann, A., Pridzun, L., Tougianidou, D., Ranke, M. B.
10.1101/2020.08.20.20174912 — Posted: 2020-08-22
Estimating healthcare resource needs for COVID-19 patients in Nigeria
Ogunbameru, A., Barrett, K., Joda, A., Khan, Y. A., Pechlivanoglou, P., Mac, S., Naimark, D., Ximenes, R., Sander, B.
10.1101/2020.08.19.20178434 — Posted: 2020-08-22
Pandemic Control in ECON-EPI Networks
Fogli, A., Perri, F., Ponder, M., Azzimonti, M.
10.1101/2020.08.19.20178087 — Posted: 2020-08-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).